WO1996038154A1 - Mittel zur behandlung von strahlenschäden - Google Patents
Mittel zur behandlung von strahlenschäden Download PDFInfo
- Publication number
- WO1996038154A1 WO1996038154A1 PCT/AT1996/000099 AT9600099W WO9638154A1 WO 1996038154 A1 WO1996038154 A1 WO 1996038154A1 AT 9600099 W AT9600099 W AT 9600099W WO 9638154 A1 WO9638154 A1 WO 9638154A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- methoxy
- represent
- alkaloids
- methyl
- Prior art date
Links
- IYCBDLDOELKMFP-SOFGYWHQSA-N CCNC(C)/N=N/C Chemical compound CCNC(C)/N=N/C IYCBDLDOELKMFP-SOFGYWHQSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Definitions
- the present invention relates to the use of phosphorus derivatives of alkaloids for the production of a medicament for the treatment of radiation damage.
- AT-PS-377 988 and AT-PS-354 644 describe processes for the preparation of new phosphorus derivatives of alkaloids or of new salts of alkaloid derivatives of thiophosphoric acid. Such compounds have a pharmacological activity and can be used as cytostatics.
- R 1 , R 2 and R 3 each independently represent H or methoxy, where R 1 and R * or R 2 and R 3 together can also represent a methylenedioxy group;
- SPARE BLADE (RULE 26) Is ring system, R 6 -CH 3 and double bonds in position 1, 2 and / or 7, 8 may be present; or
- R 6 and R 7 together with the C and N atoms to which they adhere form an optionally hydrogenated benzo or naphthoring system, which in turn can be substituted by methoxy, oxo, methyl or dioxymethyl groups, the CN -Binding in position 1, 2 may be absent and R 4 and R 5 are H;
- R 1 represents 2H, -CH 2 -CH 2 -, H or -CH 2 -CH 2 C1;
- X is 0 or N
- REPLACEMENT BLA ⁇ (RULE 26) wherein n is 1, 2 or 3; m represents 1, 2 or 3; R 1 , R 2 and R 3 each independently mean hydrogen or methoxy, where R 1 and R 2 or R 2 and R 3 together can also represent a methylene dioxy group; R 4 represents hydrogen, hydroxy or methyl; and, if R 6 is hydrogen, R 5 and R 7 together form the group
- A represents a monovalent or the equivalent part of a multivalent anion is disclosed in AT-PS 354 644.
- reaction product of the alkaloids of Chelidonium aijus L. with thiophosphoric triaziridide is used for
- REPLACEMENT BLADE (RULE 26) Provision of a drug used for the treatment or prophylaxis of radiation damage.
- the medicaments produced according to the invention preferably consist of an aqueous solution of the alkaloid phosphorus derivatives used or their salts, optionally together with other auxiliaries known per se.
- the drug according to the invention is preferably administered by injection, for example intraperitoneally, intramuscularly or intravenously, the dosage depending on the case and being related to the severity of the disease to be treated and the condition of the patient.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96914004A EP0831841A1 (de) | 1995-06-01 | 1996-05-30 | Mittel zur behandlung von strahlenschäden |
DE19680394T DE19680394D2 (de) | 1995-06-01 | 1996-05-30 | Mittel zur Behandlung von Strahlenschäden |
UA97126207A UA42842C2 (uk) | 1995-06-01 | 1996-05-30 | Спосіб лікування радіаційних пошкоджень ( варіанти ) |
AU57549/96A AU713853B2 (en) | 1995-06-01 | 1996-05-30 | Agent for the treatment of radiation injuries |
US08/981,128 US5981512A (en) | 1995-06-01 | 1996-05-30 | Means for treating radiation injuries |
NZ308024A NZ308024A (en) | 1995-06-01 | 1996-05-30 | The reaction product of alkaloids of Chelidonium maius L. with thiophosphoric acid triaziridide is used as radiation treatment medicine |
SK1625-97A SK282832B6 (sk) | 1995-06-01 | 1996-05-30 | Použitie reakčného produktu alkaloidov Chelidonium maijus L. s triaziridídom tiofosforečnej kyseliny |
JP8536023A JPH11505851A (ja) | 1995-06-01 | 1996-05-30 | 放射線障害の処置のための薬剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ATA936/95 | 1995-06-01 | ||
AT0093695A AT407833B (de) | 1995-06-01 | 1995-06-01 | Mittel zur behandlung von strahlenschäden |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996038154A1 true WO1996038154A1 (de) | 1996-12-05 |
Family
ID=3503254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AT1996/000099 WO1996038154A1 (de) | 1995-06-01 | 1996-05-30 | Mittel zur behandlung von strahlenschäden |
Country Status (15)
Country | Link |
---|---|
US (1) | US5981512A (de) |
EP (1) | EP0831841A1 (de) |
JP (1) | JPH11505851A (de) |
KR (1) | KR19990022036A (de) |
CN (1) | CN1167423C (de) |
AT (1) | AT407833B (de) |
AU (1) | AU713853B2 (de) |
CA (1) | CA2222539A1 (de) |
CZ (1) | CZ290489B6 (de) |
DE (1) | DE19680394D2 (de) |
NZ (1) | NZ308024A (de) |
SK (1) | SK282832B6 (de) |
UA (1) | UA42842C2 (de) |
WO (1) | WO1996038154A1 (de) |
ZA (1) | ZA964387B (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006032380A1 (en) * | 2004-09-20 | 2006-03-30 | Nowicky Wassili | Quaternary alkaloid derivatives of chelidonium majus l |
JP2006520763A (ja) * | 2003-03-18 | 2006-09-14 | ノヴィッキイ、 ヴァジル | 4級ケリドニン及びアルカロイド誘導体類、それらの製造法、及び医薬の製造でのそれらの使用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695417A5 (de) * | 2001-11-15 | 2006-05-15 | Ddr Wassyl Nowicky Dipl Ing | Verfahren zur Umsetzung von Alkaloiden. |
US9895331B2 (en) | 2012-07-23 | 2018-02-20 | The University Of Tokyo | Prophylactic and/or therapeutic agent for radiation damage |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT354644B (de) * | 1975-12-19 | 1980-01-25 | Nowicky Wassili | Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure |
WO1983000486A1 (en) * | 1981-07-13 | 1983-02-17 | Wassyl Nowicky | Method for the diagnostic and the therapeutic treatment of tumors and/or infectious diseases of all sorts by the use of alkaloid compositions or the salts thereof |
AT377988B (de) * | 1976-06-28 | 1985-05-28 | Nowicky Wassili | Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970212A (en) * | 1982-05-18 | 1990-11-13 | Nowicky Wassili | Method of treating human illnesses which compromise the ability to mount an effective immunological response |
US4735945A (en) * | 1986-03-13 | 1988-04-05 | Vipont Laboratories, Inc. | Method for inhibiting bone resorption and collagenase release |
EP0326627A1 (de) * | 1988-02-01 | 1989-08-09 | Vipont Pharmaceutical, Inc. | Methode zur Verhinderung der Knochenresorption und der Kollagenasefreisetzung |
-
1995
- 1995-06-01 AT AT0093695A patent/AT407833B/de not_active IP Right Cessation
-
1996
- 1996-05-29 ZA ZA964387A patent/ZA964387B/xx unknown
- 1996-05-30 SK SK1625-97A patent/SK282832B6/sk not_active IP Right Cessation
- 1996-05-30 UA UA97126207A patent/UA42842C2/uk unknown
- 1996-05-30 NZ NZ308024A patent/NZ308024A/xx unknown
- 1996-05-30 EP EP96914004A patent/EP0831841A1/de not_active Ceased
- 1996-05-30 WO PCT/AT1996/000099 patent/WO1996038154A1/de not_active Application Discontinuation
- 1996-05-30 CN CNB961948922A patent/CN1167423C/zh not_active Expired - Fee Related
- 1996-05-30 AU AU57549/96A patent/AU713853B2/en not_active Ceased
- 1996-05-30 CZ CZ19973741A patent/CZ290489B6/cs not_active IP Right Cessation
- 1996-05-30 JP JP8536023A patent/JPH11505851A/ja not_active Ceased
- 1996-05-30 KR KR1019970708515A patent/KR19990022036A/ko not_active Application Discontinuation
- 1996-05-30 CA CA002222539A patent/CA2222539A1/en not_active Abandoned
- 1996-05-30 US US08/981,128 patent/US5981512A/en not_active Expired - Fee Related
- 1996-05-30 DE DE19680394T patent/DE19680394D2/de not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT354644B (de) * | 1975-12-19 | 1980-01-25 | Nowicky Wassili | Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure |
AT377988B (de) * | 1976-06-28 | 1985-05-28 | Nowicky Wassili | Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden |
WO1983000486A1 (en) * | 1981-07-13 | 1983-02-17 | Wassyl Nowicky | Method for the diagnostic and the therapeutic treatment of tumors and/or infectious diseases of all sorts by the use of alkaloid compositions or the salts thereof |
Non-Patent Citations (3)
Title |
---|
"Ukrain", DRUGS OF THE FUTURE, vol. 20, no. 11, November 1995 (1995-11-01), pages 1207 - 1208, XP000578095 * |
DIALOG(R)FILE 72: EMBASE, ACCESSION NUMBER 9836510, XP002010212 * |
T.G.HINTON ET AL.: "Foliar absorption of resuspended 137Cs relative to other pathways of plant contamination", JOURNAL OF ENVIRONMENTAL RADIOACTIVITY, vol. 30, no. 1, 1996, pages 15 - 30 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006520763A (ja) * | 2003-03-18 | 2006-09-14 | ノヴィッキイ、 ヴァジル | 4級ケリドニン及びアルカロイド誘導体類、それらの製造法、及び医薬の製造でのそれらの使用 |
WO2006032380A1 (en) * | 2004-09-20 | 2006-03-30 | Nowicky Wassili | Quaternary alkaloid derivatives of chelidonium majus l |
Also Published As
Publication number | Publication date |
---|---|
SK282832B6 (sk) | 2002-12-03 |
CZ374197A3 (cs) | 1998-04-15 |
ATA93695A (de) | 2000-11-15 |
SK162597A3 (en) | 1998-05-06 |
AU5754996A (en) | 1996-12-18 |
JPH11505851A (ja) | 1999-05-25 |
ZA964387B (en) | 1996-12-09 |
CN1167423C (zh) | 2004-09-22 |
EP0831841A1 (de) | 1998-04-01 |
AU713853B2 (en) | 1999-12-09 |
US5981512A (en) | 1999-11-09 |
CZ290489B6 (cs) | 2002-08-14 |
NZ308024A (en) | 2000-08-25 |
CA2222539A1 (en) | 1996-12-05 |
DE19680394D2 (de) | 2000-01-27 |
UA42842C2 (uk) | 2001-11-15 |
KR19990022036A (ko) | 1999-03-25 |
CN1188412A (zh) | 1998-07-22 |
AT407833B (de) | 2001-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69734317T2 (de) | Anti-tnf antikörper / tnf rezeptor und methotrexat zur behandlung von autoimmunkrankheiten | |
CH655010A5 (de) | Pharmazeutischer wirkstoff mit antitumoraktivitaet. | |
AT389871B (de) | Verfahren zur herstellung von beta, gamma -dihydropolyprenylalkoholderivaten | |
DE2822307A1 (de) | 3,3,3-triarylalkyl-4-phenylalkyl-4- hydroxy-piperidin und verfahren zu deren herstellung | |
CH615409A5 (de) | ||
WO1996038154A1 (de) | Mittel zur behandlung von strahlenschäden | |
DE2428409C3 (de) | S3'-Bis-(3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridylmethyl)-carbonodithioat, dessen pharmakologisch verträgliche Salze und Arzneimittel | |
CH653995A5 (de) | 2beta-fluorcholecalciferole. | |
DE3424107A1 (de) | Organogermaniumverbindung und diese als wirkstoff enthaltender opioidpeptidaseinhibitor | |
DE2202690C3 (de) | Antibiotikum 27 706 RP, Verfahren zu dessen Herstellung und Arzneimittel | |
DE2822751A1 (de) | Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE2633891A1 (de) | Neues salz der alpha-methylbenzoyl- 5-thiophen-2-essigsaeure, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen | |
EP0557876A1 (de) | Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation | |
DE3105122A1 (de) | Neue piperazin-verbindungen, verfahren zu ihrer herstellung und ihre verwendung | |
DE2216717C2 (de) | Verwendung von 16-substituierten Prostaglandinderivaten zur Bekämpfung von Magengeschwüren und Steuerung der Magensekretion | |
DE3046927A1 (de) | 8-dialkylaminoalkylaether-coffein-platin-komplexe , verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
CH624397A5 (de) | ||
DE3116232A1 (de) | Nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel | |
DE2124249C3 (de) | Trans-2-chlor-l 1 -(3-piperazinyl- propyliden)-6Hdibenz- [b,e] -oxepin, Verfahren zu seiner Herstellung und pharmazeutisches Präparat | |
DE1795745C3 (de) | Arzneimittel, enthaltend 5-substituierte 4-Aza-dibenzocycloheptene | |
DE1720013A1 (de) | Tropyltropat-Derivate und Verfahren zu ihrer Herstellung | |
DE1947226B2 (de) | ll-Chlor-8,12b-dihydro-23-dimethyll2b-phenyl-4H [13] -oxazino [3,2-d] [1,4] benzodiazepin-4,7(6H)dion und Verfahren zur Herstellung dieser Verbindung | |
DE2201350A1 (de) | Aufhebung der immunsuppressiven wirkung von corticoiden | |
DE2708666A1 (de) | Arzneimittel mit immunoregulativer und antiphlogistischer wirkung | |
DE2455153A1 (de) | Arzneimittel zur bekaempfung von hyperammonaemie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96194892.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PV1997-3741 Country of ref document: CZ |
|
ENP | Entry into the national phase |
Ref document number: 2222539 Country of ref document: CA Ref document number: 2222539 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970708515 Country of ref document: KR Ref document number: 308024 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 162597 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996914004 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1996 536023 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1996 9053 Country of ref document: AT Date of ref document: 19961205 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 19969053 Country of ref document: AT |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08981128 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1996914004 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1997-3741 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970708515 Country of ref document: KR |
|
REF | Corresponds to |
Ref document number: 19680394 Country of ref document: DE Date of ref document: 20000127 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 19680394 Country of ref document: DE |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1997-3741 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: 1996914004 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019970708515 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996914004 Country of ref document: EP |